Aytu BioPharma (AYTU) Institutional Ownership $1.49 -0.11 (-6.88%) (As of 11/20/2024 ET) Add Compare Share Share Ownership Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrends Institutional Ownership Changes (13F Filings) for Aytu BioPharma (NASDAQ:AYTU)CurrentInstitutional OwnershipPercentage33.49%Number ofInstitutional Buyers(last 12 months)3TotalInstitutional Inflows(last 12 months)$827.06KNumber ofInstitutional Sellers(last 12 months)0 Get AYTU Insider Trade Alerts Want to know when executives and insiders are buying or selling Aytu BioPharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data AYTU Institutional Buying and Selling by Quarter Ad Darwin2025 AI Stock Picks: 2 Hidden Gems Under $10/ShareThe AI sector continues to make waves as we move into 2025, and now is a prime opportunity to get involved—without stretching your budget! We’ve just uncovered 2 promising AI stocks trading for under $10/share, and they’re positioned for impressive growth in the coming months.👉[Click here to get your FREE report delivered instantly!] Aytu BioPharma Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/14/2024 Stonepine Capital Management LLC500,958$1.18M0.7%+6.0%8.147% 8/15/2024 Armistice Capital LLC252,000$736K0.0%N/A4.220% 8/9/2024 Dimensional Fund Advisors LP23,551$69K0.0%+54.5%0.394% 8/16/2023 Stonepine Capital Management LLC472,369$756K0.3%N/A12.497% 8/11/2023 Stonepine Capital Management LLC472,369$756K0.3%N/A12.497% 2/7/2023Commonwealth Equity Services LLC309,558$58K0.0%+47.7%9.922% Get the Latest News and Ratings for AYTU and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Aytu BioPharma and its competitors with MarketBeat's FREE daily newsletter. 11/4/2022 Prudential Financial Inc.145,550$27K0.0%+257.2%0.233% 11/16/2021 Schonfeld Strategic Advisors LLC20,200$58K0.0%-22.8%0.073% 11/12/2021 Renaissance Technologies LLC660,604$1.90M0.0%+38.4%2.398% 11/10/2021 Creative Planning13,000$37K0.0%N/A0.047% 11/9/2021BlackRock Inc.498,952$1.44M0.0%+3.2%1.811% 10/29/2021Commonwealth Equity Services LLC107,718$310K0.0%+86.4%0.391% 9/17/2021Virtu Financial LLC101,805$510K0.0%N/A0.404% 8/17/2021 Millennium Management LLC440,415$2.21M0.0%N/A1.750% 8/16/2021 Squarepoint Ops LLC34,487$173K0.0%N/A0.137% 8/16/2021Pinz Capital Management LP21,400$107K0.0%+18.9%0.085% 8/16/2021 State Street Corp97,684$489K0.0%-44.9%0.388% 8/16/2021Tibra Equities Europe Ltd60,100$301K0.1%N/A0.239% 8/13/2021 Renaissance Technologies LLC477,369$2.39M0.0%+265.7%1.897% 8/13/2021 Northern Trust Corp47,061$236K0.0%-77.9%0.187% 8/13/2021 Geode Capital Management LLC221,439$1.11M0.0%-38.8%0.880% 8/13/2021 Vanguard Group Inc.983,387$4.93M0.0%-5.6%3.907% 8/12/2021Ergoteles LLC75,472$378K0.0%N/A0.300% 8/11/2021Commonwealth Equity Services LLC57,798$289K0.0%+24.0%0.230% 8/11/2021 Bank of New York Mellon Corp15,919$80K0.0%-66.0%0.063% 8/11/2021BlackRock Inc.483,448$2.42M0.0%-69.6%1.921% 8/11/2021 Deutsche Bank AG20,800$104K0.0%+50.9%0.083% 8/11/2021Susquehanna Fundamental Investments LLC54,819$275K0.0%+33.7%0.218% 8/10/2021 WINTON GROUP Ltd57,229$287K0.0%+22.7%0.227% 5/24/2021 Principal Financial Group Inc.42,551$323K0.0%+8.2%0.238% 5/21/2021 Citadel Advisors LLC24,761$188K0.0%-70.4%0.138% 5/18/2021 Citadel Advisors LLC24,761$188K0.0%-70.4%0.138% 5/18/2021 California State Teachers Retirement System33,011$251K0.0%+857.1%0.185% 5/17/2021 Schonfeld Strategic Advisors LLC27,100$206K0.0%N/A0.152% 5/17/2021 Armistice Capital LLC1,342,378$10.20M0.2%+0.7%7.506% 5/17/2021Pinz Capital Management LP18,000$137K0.0%N/A0.101% 5/17/2021 Nuveen Asset Management LLC276,148$2.10M0.0%N/A1.544% 5/17/2021 Goldman Sachs Group Inc.77,958$592K0.0%N/A0.436% 5/14/2021 Occudo Quantitative Strategies LP60,112$457K0.1%N/A0.336% 5/13/2021 Brandywine Global Investment Management LLC13,131$100K0.0%N/A0.073% I've got news for you… (Ad)Today, I’m doing something I thought I’d never do… Especially since I’m not normally a “swing for the fences” type of trader. But I’ve been quietly testing a new type of trade for a while now… And the returns are too good not to share with you. Take a look… I can’t guarantee results or against losses, but if you want to discover how I’ll target the triple return before the end of the weekwatch this FREE briefing with me and expert trader Graham Lindman5/13/2021 Renaissance Technologies LLC130,521$992K0.0%N/A0.730% 5/13/2021 Bank of New York Mellon Corp46,833$356K0.0%+215.2%0.262% 5/12/2021 Northern Trust Corp213,140$1.62M0.0%+335.4%1.192% 5/12/2021 Geode Capital Management LLC361,588$2.75M0.0%+249.8%2.022% 5/12/2021 JPMorgan Chase & Co.55,385$421K0.0%+634.8%0.310% 5/10/2021 Hunter Associates Investment Management LLC10,880$83K0.0%N/A0.061% 5/10/2021 Principal Financial Group Inc.42,551$323K0.0%+8.2%0.238% 5/7/2021BlackRock Inc.1,588,371$12.07M0.0%+417.7%8.882% 5/7/2021 American International Group Inc.12,755$97K0.0%+804.6%0.071% 5/6/2021 Rhumbline Advisers13,836$105K0.0%N/A0.077% 5/6/2021 Sigma Planning Corp10,722$81K0.0%N/A0.060% 5/4/2021Commonwealth Equity Services LLC46,605$354K0.0%+88.7%0.261% 5/3/2021 The Manufacturers Life Insurance Company13,682$104K0.0%N/A0.077% 2/23/2021 Principal Financial Group Inc.39,316$235K0.0%N/A0.220% 2/19/2021 JPMorgan Chase & Co.7,537$45K0.0%-78.5%0.058% 2/16/2021 Squarepoint Ops LLC34,862$208K0.0%N/A0.267% 2/16/2021 Armistice Capital LLC1,333,334$7.97M0.3%N/A7.456% 2/16/2021 Charles Schwab Investment Management Inc.11,007$66K0.0%-90.0%0.084% 2/12/2021 Stonepine Capital Management LLC1,398,776$8.37M6.4%N/A10.694% 2/11/2021 Northern Trust Corp48,951$293K0.0%-89.5%0.374% 2/9/2021 Wells Fargo & Company MN18,219$108K0.0%-87.2%0.139% 2/9/2021 Bank of New York Mellon Corp14,857$89K0.0%-81.3%0.114% 2/8/2021 New York State Common Retirement Fund6,630$40K0.0%-90.0%0.051% 2/5/2021BlackRock Inc.306,813$1.84M0.0%-89.7%2.346% 2/4/2021 Searle & CO.14,000$84K0.0%-81.3%0.107% 11/17/2020 Jane Street Group LLC56,903$68K0.0%-80.5%0.044% 11/12/2020 JPMorgan Chase & Co.34,976$42K0.0%+66.3%0.028% 11/10/2020 State Street Corp289,910$345K0.0%+26.4%0.230% 11/9/2020 Verdence Capital Advisors LLC56,542$67K0.0%-24.1%0.045% 11/9/2020 LPL Financial LLC24,100$29K0.0%N/A0.019% 11/6/2020BlackRock Inc.2,975,685$3.54M0.0%+168.8%2.365% (Data available from 1/1/2016 forward) AYTU Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of AYTU shares? During the previous two years, the following institutional investors and hedge funds held shares of Aytu BioPharma shares: Stonepine Capital Management LLC ($1.18M), Armistice Capital LLC ($736K), and Dimensional Fund Advisors LP ($69K), Commonwealth Equity Services LLC ($58K).Learn more on AYTU's institutional investors. What percentage of Aytu BioPharma stock is owned by institutional investors? 33.49% of Aytu BioPharma stock is owned by institutional investors. Learn more on AYTU's institutional investor holdings. Which institutional investors have been buying Aytu BioPharma stock? The following institutional investors have purchased Aytu BioPharma stock in the last 24 months: Stonepine Capital Management LLC ($973.23K), Armistice Capital LLC ($252K), Commonwealth Equity Services LLC ($100K), and Dimensional Fund Advisors LP ($8.31K). How much institutional buying is happening at Aytu BioPharma? Institutional investors have bought a total of 1,333,538 shares in the last 24 months. This purchase volume represents approximately $2.36M in transactions. Related Companies NextCure Major Shareholders Carisma Therapeutics Major Shareholders HCW Biologics Major Shareholders Barinthus Biotherapeutics Major Shareholders Lexaria Bioscience Major Shareholders Elevation Oncology Major Shareholders Clene Major Shareholders Estrella Immunopharma Major Shareholders ProMIS Neurosciences Major Shareholders ImmuCell Major Shareholders This page (NASDAQ:AYTU) was last updated on 11/20/2024 by MarketBeat.com Staff From Our PartnersTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. ...Colonial Metals | SponsoredThe smart-money is buying this US$1 lithium stockLithium is getting white-hot once again! And that means well-timed investors who position now in the best n...Resource Stock Digest | SponsoredAre Your Retirement Savings Really Safe?What They Don’t Want You to Know About Your 401(k)The 2008-2010 crisis wiped out almost 50% of the value of retirement funds. If you knew it was coming, wouldn'...American Hartford Gold | SponsoredDeFi Coin on Verge of Breakout!The blueprint for millionaires is here. Don't let this be the missed opportunity you regret for years. Crypto 101 Media | SponsoredMy favorite credit card just increased its sign-up bonusTired of getting average credit card rewards? This credit card just increased its sign-up bonus to 75,000 bonu...Card Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aytu BioPharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aytu BioPharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
